Anzeige
Mehr »
Login
Mittwoch, 08.04.2020 Börsentäglich über 12.000 News von 626 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 565131 ISIN: DK0010272202 Ticker-Symbol: GE9 
Tradegate
08.04.20
08:17 Uhr
192,20 Euro
-1,35
-0,70 %
1-Jahres-Chart
GENMAB A/S Chart 1 Jahr
5-Tage-Chart
GENMAB A/S 5-Tage-Chart
RealtimeGeldBriefZeit
194,40
195,20
10:48
194,60
194,90
10:48

Aktuelle News zur GENMAB Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.04.Nasdaq Copenhagen A/S: Genmab A/S - admittance to trading and official listing of new shares due to employee warrant exercise159The share capital of Genmab A/S has been increased. The admittance to trading and official listing will take effect as per 3 April 2020 in the ISIN below. ISIN: DK0010272202 ...
► Artikel lesen
GENMAB Aktie jetzt für 4€ handeln
31.03.Genmab A/S: Capital Increase in Genmab as a Result of Employee Warrant Exercise-
31.03.GENMAB A/S - 6-K, Report of foreign issuer2
30.03.Genmab A/S: Genmab Files Annual Report with the U.S. Securities and Exchange Commission-
26.03.Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons3
26.03.Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and a New Member of ...-
26.03.Passing of Genmab A/S' Annual General Meeting-
24.03.GENMAB A/S - 6-K, Report of foreign issuer4
16.03.Genmab: An Attractive Biotechnology Platform Pick In March 202022
12.03.Genmab A/S Provides Update to Annual General Meeting11
11.03.Genmab hires first chief operating officer4
11.03.The J&J/Genmab alliance that hit big in multiple myeloma now has a new 'breakthrough' in NSCLC to boast about12
10.03.GENMAB A/S - 6-K, Report of foreign issuer1
10.03.Genmab A/S: Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer2
27.02.Notice to Convene the Annual General Meeting of Genmab A/S1
27.02.Nasdaq Copenhagen A/S: Genmab A/S - admittance to trading and official listing of new shares due to employee warrant exercise134The share capital of Genmab A/S has been increased. The admittance to trading and official listing will take effect as per 28 February 2020 in the ISIN below. ISIN: DK0010272202...
► Artikel lesen
25.02.GENMAB A/S - 6-K, Report of foreign issuer-
25.02.Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons1
25.02.Genmab A/S: Capital Increase in Genmab as a Result of Employee Warrant Exercise4
24.02.Genmab: Zulassungsfortschritte bei Ofatumumab von enormer Bedeutung1.052Kulmbach (www.aktiencheck.de) - Genmab-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von Genmab A/S (ISIN: DK0010272202...
► Artikel lesen
Seite:  Weiter >>
84 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2